| View |
|
DRP-15684
|
Dorzolamide (as hydrochloride) + Timolol (as maleate)
|
Dorza-T
|
20 mg/5 mg
|
Ophthalmic Solution (Eye Drops)
|
Antiglaucoma
|
World Medicine İlaç San Ve Tic. A.Ş.
|
Turkey
|
Initial
|
22 August 2024
|
22 August 2029
|
| View |
|
DRP-15674
|
Dopamine hydrochloride
|
Dhoparal
|
40 mg/mL (200 mg/5 mL)
|
Solution for Injection (I.V.
Infusion)
|
Adrenergic and Dopaminergic Agent
|
Hiral Labs Limited
|
India
|
Initial
|
22 August 2024
|
22 August 2029
|
| View |
|
DRP-15673
|
Sodium valproate
|
Soval Elixir
|
200 mg/5 mL (4 g/100 mL)
|
Oral Solution
|
Antiepileptic (Fatty acid Derivative)
|
Shine Pharmaceuticals Limited
|
India
|
Initial
|
22 August 2024
|
22 August 2029
|
| View |
|
BRP-100-13
|
Epoetin Alfa
|
Gotein
|
4000 IU / mL
|
Solution for Injection (IV/SC)
|
Antianemic Preparations
|
Shenyang Sunshine Pharmaceutical Co., Ltd.
|
China
|
CLIDP Conversion
|
20 August 2024
|
14 December 2026
|
| View |
|
BRP-100-14
|
Epoetin Alfa
|
Aropotin
|
4000 IU/ mL
|
Solution for Injection (IV/SC)
|
Antianemic Preparations
|
Shenyang Sunshine Pharmaceutical Co., Ltd.
|
China
|
CLIDP Conversion
|
23 August 2024
|
14 December 2026
|
| View |
|
BRP-100-15
|
Epoetin Alfa
|
Eporife
|
4000 IU/ mL
|
Solution for Injection (IV /SC)
|
Antianemic Preparations
|
Shenyang Sunshine Pharmaceutical Co., Ltd
|
China
|
CLIDP Conversion
|
08 September 2024
|
14 December 2026
|
| View |
|
BRP-141-01
|
Tetanus Toxoid Adsorbed
|
Nue-Tat
|
40 IU/0.5 mL
|
Suspension for Injection (IM)
|
Vaccine
|
Amson Vaccines & Pharma (Pvt.) Ltd.
|
Pakistan
|
CLIDP Conversion
|
20 August 2024
|
24 August 2027
|
| View |
|
DRHR-1676
|
Ascorbic Acid
|
None
|
100 mg/5 mL
|
Syrup
|
Vitamin
|
NORTHFIELD LABORATORIES, INC.
|
Philippines
|
CLIDP Conversion
|
25 August 2024
|
18 August 2029
|
| View |
|
DRP-10190-01
|
Cisplatin
|
Zahir
|
1 mg/mL
|
Solution for injection (IV)
|
Antineoplastic
|
Khandelwal Laboratories Pvt. Ltd
|
India
|
CLIDP Conversion
|
08 September 2024
|
11 September 2029
|
| View |
|
DRP-10196-01
|
Doxorubicin Hydrochloride
|
Haelan-10
|
10 mg
|
Lyophilized Powder for Injection (IV)
|
Antineoplastic (Anthracycline and related substance)
|
Khandelwal Laboratories Pvt. Ltd.
|
India
|
CLIDP Conversion
|
04 September 2024
|
01 October 2026
|
| View |
|
DRP-10197-01
|
Doxorubicin Hydrochloride
|
Haelan-50
|
50 mg
|
Lyophilized Powder for Injection (IV)
|
Antineoplastic (Anthracycline and related substance)
|
Khandelwal Laboratories Pvt. Ltd.
|
India
|
CLIDP Conversion
|
04 September 2024
|
01 October 2026
|
| View |
|
DRP-10246-13
|
Ceftriaxone (as sodium)
|
Martriaxone
|
1 g
|
Powder for Injection (IM/IV)
|
Antibacterial (Third-Generation Cephalosporin)
|
Theon Pharmaceuticals Limited
|
India
|
CLIDP Conversion
|
04 September 2024
|
01 October 2026
|
| View |
|
DRP-10356-02
|
Sevelamer Carbonate
|
Xelafos
|
800 mg
|
Film-Coated Tablet
|
Phosphate Binder
|
Medisure Laboratories Pakistan (Pvt.) Ltd
|
Pakistan
|
CLIDP Conversion
|
04 September 2024
|
16 September 2026
|
| View |
|
DRP-10878-09
|
Clopidogrel (as bisulfate)
|
Primevix
|
75 mg
|
Film-Coated Tablet
|
Antithrombotic Agent (Platelet Aggregation Inhibitor)
|
Magbro Healthcare Pvt. Ltd.
|
India
|
CLIDP Conversion
|
08 September 2024
|
10 December 2026
|
| View |
|
DRP-11044-09
|
Potassium Citrate
|
Keltiqo
|
1080 mg
|
Extended-Release Tablet
|
Antiurolithic
|
Magbro Healthcare Pvt. Ltd.
|
India
|
CLIDP Conversion
|
08 September 2024
|
18 January 2027
|
| View |
|
DRP-11138-02
|
Biperiden hydrochloride
|
None
|
2 mg
|
Tablet
|
Anticholinergic Agent (Tertiary Amine)
|
LifeSquare Laboratories, Inc.
|
Philippines
|
CLIDP Conversion
|
20 August 2024
|
07 February 2027
|
| View |
|
DRP-11138-03
|
Biperiden hydrochloride
|
None
|
2 mg
|
Tablet
|
Anticholinergic Agent (Tertiary Amine)
|
Lifesquare Laboratories Inc.
|
Philippines
|
CLIDP Conversion
|
04 September 2024
|
07 February 2027
|
| View |
|
DRP-11462-06
|
Piperacillin (as sodium) + Tazobactam (as sodium)
|
Duopro
|
4 g/ 500 mg
|
Powder for Injection (I.V.)
|
Antibacterial (Penicillin-Beta-Lactamase Inhibitor Combination)
|
Reyoung Pharmaceutical Co., Ltd.
|
China
|
CLIDP Conversion
|
23 August 2024
|
15 March 2027
|
| View |
|
DRP-11620-08
|
Febuxostat
|
Febutech
|
40 mg
|
Film-Coated Tablet
|
Antigout
|
Gracure Pharmaceutical Ltd.
|
India
|
CLIDP Conversion
|
04 September 2024
|
04 April 2027
|
| View |
|
DRP-11990-02
|
Meclizine Hydrochloride
|
Melzin
|
25mg
|
Chewable Tablet (Orange Flavor)
|
Anti-emetic
|
Azarias Pharmaceutical Laboratories Inc
|
Philippines
|
CLIDP Conversion
|
04 September 2024
|
06 June 2027
|